WO2006118034A1 - 薬液容器収容体およびその製造方法 - Google Patents
薬液容器収容体およびその製造方法 Download PDFInfo
- Publication number
- WO2006118034A1 WO2006118034A1 PCT/JP2006/308206 JP2006308206W WO2006118034A1 WO 2006118034 A1 WO2006118034 A1 WO 2006118034A1 JP 2006308206 W JP2006308206 W JP 2006308206W WO 2006118034 A1 WO2006118034 A1 WO 2006118034A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- plastic
- chemical
- oxygen
- layer
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 25
- 230000008569 process Effects 0.000 title claims abstract description 9
- 229920003023 plastic Polymers 0.000 claims abstract description 181
- 239000004033 plastic Substances 0.000 claims abstract description 181
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 144
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 143
- 239000001301 oxygen Substances 0.000 claims abstract description 143
- 230000035699 permeability Effects 0.000 claims abstract description 119
- 230000001954 sterilising effect Effects 0.000 claims abstract description 116
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 116
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 98
- 230000004888 barrier function Effects 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims description 159
- 239000010410 layer Substances 0.000 claims description 145
- 239000000243 solution Substances 0.000 claims description 102
- 239000003186 pharmaceutical solution Substances 0.000 claims description 45
- 239000003814 drug Substances 0.000 claims description 35
- 229940079593 drug Drugs 0.000 claims description 35
- 239000011241 protective layer Substances 0.000 claims description 26
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 23
- 239000005977 Ethylene Substances 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 229920000098 polyolefin Polymers 0.000 claims description 20
- 238000007789 sealing Methods 0.000 claims description 19
- 229940123973 Oxygen scavenger Drugs 0.000 claims description 18
- 238000010521 absorption reaction Methods 0.000 claims description 13
- 229920005862 polyol Polymers 0.000 claims description 13
- 150000003077 polyols Chemical class 0.000 claims description 13
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 claims description 10
- 239000012298 atmosphere Substances 0.000 claims description 10
- 239000011261 inert gas Substances 0.000 claims description 10
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 5
- 239000012476 oxidizable substance Substances 0.000 claims description 5
- 125000003367 polycyclic group Polymers 0.000 claims description 3
- 150000001336 alkenes Chemical class 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 238000010828 elution Methods 0.000 abstract description 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000003635 deoxygenating effect Effects 0.000 abstract 1
- 239000012778 molding material Substances 0.000 abstract 1
- 238000010137 moulding (plastic) Methods 0.000 abstract 1
- 239000004698 Polyethylene Substances 0.000 description 55
- -1 polyethylene Polymers 0.000 description 42
- 229920000573 polyethylene Polymers 0.000 description 23
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 21
- 239000004743 Polypropylene Substances 0.000 description 20
- 239000012790 adhesive layer Substances 0.000 description 17
- 229920001577 copolymer Polymers 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000001464 adherent effect Effects 0.000 description 12
- 238000001802 infusion Methods 0.000 description 12
- 239000002985 plastic film Substances 0.000 description 12
- 229920006255 plastic film Polymers 0.000 description 11
- 229920001155 polypropylene Polymers 0.000 description 11
- 230000006866 deterioration Effects 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 229920001971 elastomer Polymers 0.000 description 6
- 239000000806 elastomer Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000003978 infusion fluid Substances 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 5
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 5
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 4
- 229920002292 Nylon 6 Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 229920001400 block copolymer Polymers 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- BXOUVIIITJXIKB-UHFFFAOYSA-N ethene;styrene Chemical group C=C.C=CC1=CC=CC=C1 BXOUVIIITJXIKB-UHFFFAOYSA-N 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- 239000004840 adhesive resin Substances 0.000 description 3
- 229920006223 adhesive resin Polymers 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229910052809 inorganic oxide Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 150000002829 nitrogen Chemical class 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 238000007142 ring opening reaction Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229920006132 styrene block copolymer Polymers 0.000 description 2
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 2
- 229920001935 styrene-ethylene-butadiene-styrene Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- RLRINNKRRPQIGW-UHFFFAOYSA-N 1-ethenyl-2-[4-(2-ethenylphenyl)butyl]benzene Chemical compound C=CC1=CC=CC=C1CCCCC1=CC=CC=C1C=C RLRINNKRRPQIGW-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MLJRLEGXZUNRLY-UHFFFAOYSA-N 2,4-ditert-butylphenol;phosphorous acid Chemical compound OP(O)O.CC(C)(C)C1=CC=C(O)C(C(C)(C)C)=C1.CC(C)(C)C1=CC=C(O)C(C(C)(C)C)=C1.CC(C)(C)C1=CC=C(O)C(C(C)(C)C)=C1 MLJRLEGXZUNRLY-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004230 Fast Yellow AB Substances 0.000 description 1
- USXDFAGDIOXNML-UHFFFAOYSA-N Fulminate Chemical compound [O-][N+]#[C-] USXDFAGDIOXNML-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N butyl alcohol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 229910001567 cementite Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 150000002506 iron compounds Chemical class 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 239000002651 laminated plastic film Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid group Chemical group C(\C=C/C(=O)O)(=O)O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920005638 polyethylene monopolymer Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- 229920005629 polypropylene homopolymer Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 229920001384 propylene homopolymer Polymers 0.000 description 1
- 238000009517 secondary packaging Methods 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1379—Contains vapor or gas barrier, polymer derived from vinyl chloride or vinylidene chloride, or polymer containing a vinyl alcohol unit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1379—Contains vapor or gas barrier, polymer derived from vinyl chloride or vinylidene chloride, or polymer containing a vinyl alcohol unit
- Y10T428/1383—Vapor or gas barrier, polymer derived from vinyl chloride or vinylidene chloride, or polymer containing a vinyl alcohol unit is sandwiched between layers [continuous layer]
Definitions
- the present invention relates to a chemical solution container housing body in which a chemical solution container filled and sealed with a chemical solution is accommodated in an outer bag and sealed, and a method for manufacturing the same.
- plastic containers for storing chemical solutions have been widely used as plastic containers that are lightweight, flexible, easy to handle, and easy to dispose of.
- plastics polyolefins such as polyethylene and polypropylene are frequently used from the viewpoint of stability to chemical solutions and pharmaceutical safety.
- polyolefin is a material having a high oxygen permeability, it is not necessarily suitable for the purpose of storing and storing a chemical solution that easily undergoes oxidative degradation from the viewpoint of maintaining the quality of the chemical solution.
- Patent Document 1 an infusion solution comprising an aqueous solution containing an amino acid is filled in a primary medical container having gas permeability, and the infusion agent filled in the primary medical container is a deoxidizing agent.
- an infusion solution package characterized by being housed in a secondary packaging container that is substantially impermeable to oxygen is described.
- Patent Document 2 describes a chemical container film having the following properties (1) to (4), wherein an inorganic compound film is formed on at least one surface of a plastic film.
- Oxygen permeability is 1 ccZm 2 ⁇ 24hr ⁇ atm or less;
- Moisture permeability is lgZm 2 '24hr'atm or less
- Hue b value is 5 or less.
- Patent Document 3 includes a resin container having a flexible wall having at least a discharge port, and the container wall is divided into an inner layer and an outer layer with an intermediate layer of polyvinyl alcohol as a boundary.
- the innermost layer is a polyolefin layer with a thickness in the range of 50 to 800 m.
- the moisture permeability of the outer layer So (g / m 4hrs: temperature 40 ° C, 90% RH) is 2 of the moisture permeability Si (g / m 2 24hrs: temperature 40 ° C, 90% RH) of the inner layer.
- an infusion container having gas noriality characterized in that the outer layer is provided so as to be twice or more, and an infusion container in which this container is packaged in a package in the presence of a desiccant. Has been.
- this document describes that the gas innocence of the container wall is immediately recovered even after the infusion container is autoclaved.
- Patent Document 1 Japanese Patent Laid-Open No. 63-275346
- Patent Document 2 Japanese Patent Laid-Open No. 11-285520
- Patent Document 3 Japanese Patent Laid-Open No. 10-80464
- oxygen barrier plastic a plastic film having an oxygen barrier property
- a plastic film or an aluminum film on which silica or alumina is deposited is used as a conventional plastic film having an oxygen barrier property.
- Plastic films using inorganic materials such as laminated plastic films are known.
- a chemical container formed using an oxygen-nore plastic film is excellent in the oxygen-nore property of the film. If the space is sealed with oxygen, the contents will deteriorate over time, and if the bacteria are mistakenly mixed in the chemical solution, the bacteria will not grow. Absent. Therefore, before filling and sealing the chemical solution in the chemical solution container, treatment to reduce dissolved oxygen in the chemical solution is performed, or the head space is replaced with an inert gas such as nitrogen, and the replacement rate is 100%. As a result, the manufacturing equipment becomes complicated and heavy, leading to increased costs. . However, the above-mentioned oxygen-nore plastic may cause a pinhole due to an impact caused by vibration during transportation.
- plastics having oxygen-noria properties for example, polysalt-vinylidene, polyacrylo-tolyl, polybulual alcohol, ethylene butyalcohol copolymer, and the like are known, and these are formed into a film shape. It is also supplied as a product.
- plastic films do not have sufficient heat resistance, impact resistance, flexibility, transparency, etc., are not suitable for incineration at the time of disposal, or are in contact with chemicals to remove eluate. It may not occur, so it is not appropriate to use it as it is to form a chemical container.
- polybulal alcohol or ethylene butyalcohol copolymer has the disadvantage that the oxygen barrier properties fluctuate greatly due to changes in humidity.
- Patent Document 3 describes that the gas barrier property of the infusion container is recovered immediately after the autoclave sterilization treatment. Oxygen present in the infusion container is not considered at all. However, problems such as oxidative deterioration of contents over time and bacterial growth have not been solved.
- the object of the present invention is to maintain the properties required for plastic pharmaceutical liquid containers, including heat resistance, impact resistance, flexibility, transparency, and elution resistance for plastic forming materials.
- Another object of the present invention is to provide a chemical container container capable of highly suppressing deterioration of chemicals accompanying bacterial permeation and bacterial growth, and a method for producing the same.
- the present invention provides:
- the steam sterilization treatment is a treatment in which the plastic pharmaceutical solution container is heated for 10 to 60 minutes in an inert gas atmosphere at a temperature of 100 to 121 ° C. and in a steam saturated state, (1) the chemical container container,
- the plastic forming the plastic pharmaceutical solution container is a multilayer film, and has a seal layer having a polyolefin-based plastic force on the inner side surface of the plastic pharmaceutical solution container, and is disposed outside the plastic pharmaceutical solution container.
- the water vapor permeability force of the entire layer provided on the outer surface side of the plastic pharmaceutical solution container from the intermediate layer is 1 to 50 gZm 2 '24h at a temperature of 25 ° C and a humidity of 90% RH.
- the chemical container container according to (3) characterized in that:
- the plastic forming the plastic pharmaceutical solution container has an oxygen permeability of 500-1000 cm 3 at a temperature of 25 ° C and humidity of 60% RH within 12 hours after being subjected to steam sterilization or hot water sterilization. / m 2 '24h'atm, the chemical container container according to (1) above,
- the plastic forming the plastic pharmaceutical solution container has an oxygen permeability of 0.5 to 70 cm 3 Zm 2 '2 at a temperature of 25 ° C and a humidity of 60% RH when the oxygen permeability is in a steady state.
- the outer packaging bag has a water vapor permeability at a temperature of 25 ° C. and a humidity of 90% RH of 0.5 to 30 gZm 2 ′ 24 h. ,
- Oxygen permeability at a temperature of 25 ° C and humidity of 60% RH within 12 hours after steam sterilization or hot water sterilization is 200 cm 3 Zm 2 '24h'atm or more, and oxygen
- the drug solution is housed in a plastic drug container made of plastic with a permeability of 10 OcmVm 2 24h 'atm or less at a temperature of 25 ° C and a humidity of 60% RH when the permeability is steady.
- the plastic drug container is steam sterilized or hot water sterilized, and then the plastic drug container after steam sterilization or hot water sterilization is treated with an oxygen scavenger.
- a method of manufacturing a container for a chemical solution which is housed in an outer bag having a sealed structure and sealed.
- the steam sterilization treatment is a treatment in which the plastic pharmaceutical solution container is heated for 10 to 60 minutes in an inert gas atmosphere at a temperature of 100 to 121 ° C. and in a steam saturated state, (13)
- the outer packaging bag has a water vapor permeability at a temperature of 25 ° C. and a humidity of 90% RH of 0.5 to 30 gZm 2 ′ 24h, (13) Manufacturing method,
- the plastic drug container and the oxygen scavenger are accommodated in the outer bag and sealed before the space between the plastic drug container and the outer bag is filled with an inert gas.
- the oxygen permeability (O GTR) of plastic is JIS K 7126 “Plastic
- Method A (as defined in “Testing method for water vapor permeability of sticky films and sheets (instrument measurement method)") Measured according to the humidity sensor method).
- the oxygen permeability is preferably a measured value within 8 hours after steam sterilization or hot water sterilization, and more preferably within 6 hours after steam sterilization or hot water sterilization. It is a measured value. In general, it takes about 4 hours to lower the temperature of the plastic that has been subjected to steam sterilization or hot water sterilization to 25 ° C, which is the measurement temperature for oxygen permeability, by cooling. .
- the steam sterilization treatment or the hot water sterilization treatment is preferably performed at normal pressure or under a pressurized atmosphere at a pressure of 40 OOhPa or less, more preferably at a pressure of 2000 to 35 OOhPa. It is performed under a pressurized atmosphere.
- the above steady state means that the oxygen permeability (for example, the oxygen permeability measured under certain conditions such as temperature of 25 ° C and humidity of 60% RH) over time is ⁇ 5% per hour. Within, preferably when within ⁇ 3%.
- the plastic pharmaceutical liquid container in the chemical container container of the present invention has an oxygen permeability of 100 cm 3 Zm in an environment of a temperature of 25 ° C and a humidity of 60% RH when the oxygen permeability is in a steady state. 2 ⁇ 24h ⁇ atm or less, V, formed of a so-called low oxygen permeable plastic.
- V formed of a so-called low oxygen permeable plastic.
- the plastic forming the plastic pharmaceutical solution container has an oxygen permeability of 200 cm 3 in an environment at a temperature of 25 ° C and a humidity of 60% RH after steam sterilization or hot water sterilization. / m 2 ⁇ 24h ⁇ atm or more, and oxygen permeability is extremely high compared to when oxygen permeability is in a steady state.
- the oxygen permeability of plastic after steam sterilization or hot water sterilization usually does not rapidly return to the state before steam sterilization or hot water sterilization.
- the chemical container after steam sterilization treatment or hot water sterilization treatment is housed in an outer bag having oxygen barrier properties together with a deoxidizing agent until the oxygen permeability of the plastic is greatly reduced, and sealed.
- oxygen remaining in the chemical liquid container for example, oxygen remaining in the head space of the chemical liquid container or dissolved oxygen in the chemical liquid
- the oxidative deterioration of the chemical liquid stored in the chemical container can be highly suppressed. Moreover, even if a small amount of bacteria are mistakenly mixed, the growth can be highly suppressed.
- FIG. 1 is a schematic cross-sectional view showing an embodiment of plastic forming a plastic pharmaceutical solution container.
- FIG. 2 is a schematic cross-sectional view showing another embodiment of the plastic forming the plastic pharmaceutical solution container.
- FIG. 3 is a schematic cross-sectional view showing still another embodiment of the plastic forming the plastic pharmaceutical solution container.
- FIG. 4 is a front view showing one embodiment of a chemical solution bag.
- FIG. 5 is a graph showing the change with time in oxygen permeability of the multilayer film obtained in Example 1.
- FIG. 6 is a graph showing the change over time in the dissolved oxygen concentration of the chemical container containers obtained in the examples and comparative examples.
- FIG. 7 is a graph showing changes over time in the dissolved oxygen concentration of the chemical liquid containers (chemical liquid bags) obtained in Examples and Comparative Examples.
- FIG. 8 is a graph showing changes with time in oxygen permeability of the multilayer film obtained in Example 1 in a state of being accommodated in an outer bag.
- the chemical liquid container container of the present invention includes a plastic pharmaceutical liquid container that contains and seals a chemical liquid and is subjected to steam sterilization treatment or hydrothermal sterilization treatment, an oxygen scavenger, and the plastic pharmaceutical liquid container and oxygen scavenger. And an exterior bag for storing and sealing the container.
- the plastic pharmaceutical container has an oxygen permeability of 200 cm 3 at a temperature of 25 ° C. and a humidity of 60% RH within 12 hours after being subjected to steam sterilization or hot water sterilization. / m 2 '24h'atm or more and plastic with oxygen permeability at steady state of 25 ° C and humidity 60% RH of 100cm 3 Zm 2 '24h'atm or less It is formed by.
- the oxygen permeability at a temperature of 25 ° C and a humidity of 60% RH within 12 hours after the steam sterilization or hot water sterilization of the plastic is particularly preferable in the above range.
- the oxygen permeability at a temperature of 25 ° C and a humidity of 60% RH within 12 hours after the steam sterilization treatment or hot water sterilization treatment of the plastic is below the above range, After steam sterilization treatment or hot water sterilization treatment for plastic pharmaceutical liquid containers, the effect of removing oxygen contained in the head space in plastic pharmaceutical liquid containers and dissolved oxygen in chemical liquids to the outside also decreases. In other words, the effect of suppressing or preventing the deterioration of acid and sour in the chemical solution will be reduced.
- the upper limit of oxygen permeability after steam sterilization or hot water sterilization is not particularly limited, but the upper limit is about 1000 cm 3 Zm 2 ⁇ 24 h 'atm due to the nature of plastic used for plastic pharmaceutical liquid containers. .
- the oxygen permeability at a temperature 25 ° C, humidity of 60% RH when the oxygen permeability is in a steady state among the above range, preferably, 70cmVm 2 - 24h- atm or less More preferably 30 cm 3 Zm 2 ′ 24 h′atm or less, and still more preferably 0.5 to: LO cm 3 Zm 2 ′ 24 h ′ atm.
- the plastic oxygen permeability force at a temperature of 25 ° C and humidity of 60% RH when the oxygen permeability is in a steady state. If the above range is exceeded, for example, after opening the outer packaging bag of the chemical container container, the above When the chemical solution container is left unattended, the permeation of oxygen into the chemical solution container cannot be suppressed, and the chemical solution contained in the chemical solution container causes deterioration of the acidity of the chemical solution.
- the lower limit of oxygen permeability when the oxygen permeability is in a steady state is preferably zero, but 0.5 cm 3 Zm 2 '24h' atm due to the nature of plastic used in plastic pharmaceutical liquid containers The degree is preferred.
- the lower limit of the oxygen permeability, lcmVm 2 - 24 h 'Yogumata be about atm, 5cm 3 Zm 2' may be about 24H'atm.
- the oxygen permeability of plastic is JIS K 7126 "Plastic
- Oxygen permeability measured according to the B method (isobaric method) specified in “Testing methods for gas permeability of films and sheets”. As a measuring instrument used to measure oxygen permeability
- the treatment conditions of the steam sterilization treatment or the hot water sterilization treatment for the plastic pharmaceutical liquid container are not particularly limited, and specifically, according to the general treatment conditions of the sterilization treatment for the container containing the chemical solution. If, for example, the type and amount of the chemical solution to be contained, the material of the plastic forming the container, the thickness, etc. are set appropriately, and the sterilization treatment for the liquid content should be set appropriately to meet the intended conditions. Good.
- the heating time may be 10 to 60 minutes in an atmosphere of a temperature of 100 to 121 ° C and a steam saturated state.
- the pressurizing conditions during the steam sterilization treatment are not particularly limited, but are preferably normal pressure or pressurized at a pressure of 4000 hPa or less, more preferably at a pressure of 2000 to 3500 hPa.
- the hot water sterilization treatment may be performed in accordance with conventionally known conditions or steam sterilization treatment conditions.
- hot water at about 100 to 120 ° C. is used under normal pressure or under pressure. Just spray or spray for about 60 minutes.
- the steam sterilization treatment or hot water sterilization treatment is preferably performed in an inert gas atmosphere.
- the head space of the chemical container before being stored and sealed in the outer bag can be replaced to some extent by the inert gas during the steam sterilization process or hot water sterilization process, and is stored in the outer bag.
- the amount of oxygen contained in the chemical container before sealing can be reduced in advance.
- the amount of oxygen scavenger required to remove oxygen in the chemical container and the time required for deoxygenation after the chemical container is stored in the outer bag and sealed can be reduced. It is possible to further improve the effect of suppressing and preventing deterioration.
- the inert gas is not particularly limited !, but is, for example, a gas such as nitrogen or argon that is unlikely (preferably not generated) to cause oxidation or other alteration to a chemical solution. It is preferable.
- the oxygen permeability after steam sterilization treatment or hot water sterilization treatment or the steady state oxygen permeability of the plastic forming the plastic pharmaceutical solution container can be changed by changing the plastic type, thickness, etc.
- the plastic is a multilayer film, it can be set to an appropriate value by changing the layer configuration, thickness, and the like.
- the oxygen permeability of the plastic forming the plastic pharmaceutical solution container is the oxygen permeability value after the steam sterilization treatment or the hot water sterilization treatment, and the oxygen permeability in the steady state.
- a polyol-based plastic as a plastic for forming the chemical solution container.
- polyol plastics include, but are not limited to, ethylene-vinyl And alcohol alcohol copolymers.
- ethylene content of ethylene is 10 to 45 mole 0/0 - Byurua alcohol copolymer.
- the ethylene content of the ethylene Bulle alcohol copolymer falls below 10 mol 0/0, for example, there may not come a sufficient water resistance to withstand steam sterilization or hot water sterilization at secured.
- the oxygen permeability increased by steam sterilization or hot water sterilization may not be restored even after the temperature of the plastic is lowered.
- the above-mentioned polyol-based plastic may be, for example, a polyamide-based resin (for example, nylon-6) or a phosphorus-based antioxidant (for example, for example).
- a polyamide-based resin for example, nylon-6
- a phosphorus-based antioxidant for example, for example
- Tris (2,4 di-t-butylphenol) phosphite, etc.) can be blended.
- the blending amount of these polyamide-based phosphatase-based anti-oxidation agents should be set within a range that does not affect the chemical solution contained in the chemical solution container.
- the plastic forming the plastic pharmaceutical liquid container has a polyol-based plastic as an intermediate layer, which is closer to the inner surface side of the chemical liquid container than the intermediate layer. It is desirable that the plastic film has a multilayer structure in which a sealing layer (innermost layer) having a plastic force is provided and a protective layer (outermost layer) is provided on the outer surface side of the chemical solution container from the intermediate layer.
- the sealing layer (innermost layer) forms a welding surface when the peripheral edge of a plastic film is welded to form, for example, an infusion bag or the like, and the inner surface of the chemical solution container It forms a surface that comes into direct contact with the chemical solution. Therefore, As the plastic forming the sealing layer (innermost layer), for example, heat sealing is required and safety against chemicals is established.
- plastic for forming the seal layer include, for example, polyolefin plastic.
- Polyolefin plastics include, for example, polyethylene (ethylene homopolymer), ethylene a -olefin copolymer, polypropylene (propylene homopolymer), propylene 'a-olefin random copolymer, propylene' a-olefin block copolymer.
- a-olefins in the ethylene'a-olefin copolymers include, for example, ⁇ -olefins having 3 to 6 carbon atoms such as propylene, 1-butene, 1-pentene, 1-hexene, and 4-methyl-1-pentene.
- Examples of the a-olefin used in the propylene 'a olefin random copolymer and propylene' a -olefin block copolymer include, for example, ethylene, or, for example, 1-butene, 1 pentene, 1-hexene, 4-methyl. Examples include ⁇ -olefins having 4 to 6 carbon atoms such as 1-pentene.
- the polyolefin plastic used for the seal layer is preferably polyethylene, polypropylene, or a mixed resin thereof.
- the sealing layer is preferably formed of a plastic made of a mixed resin of polyethylene and polypropylene.
- the protective layer (outermost layer) is a layer forming the outer surface of the plastic pharmaceutical solution container. Therefore, as a plastic for forming the protective layer (outermost layer), for example, in the steam sterilization process or the hot water sterilization process, the intermediate layer that is the polyol plastic force is not directly affected by moisture. From the viewpoint of maintaining a predetermined strength according to the viewpoint and the shape and application of the chemical solution container, it may be appropriately selected.
- the entire layer provided on the outer surface side of the plastic pharmaceutical liquid container with respect to the intermediate layer is preferably the polyol-based layer.
- the intermediate layer having plastic strength is directly affected by moisture, it is required to have a certain water vapor permeability for the effect of the present invention.
- the water vapor permeability of the protective layer is not particularly limited, but the temperature is 25 ° C, the humidity in 90% RH, preferably, 'a 24h, more preferably, 3 ⁇ 30gZm 2' l ⁇ 50gZm 2 is 24h, more preferably, 3: a LOg / m 2 '24h.
- the water vapor transmission rate is JIS K 7129 "of plastic films and sheets.
- Method A moisture sensitive sensor method specified in “Water vapor permeability test method (instrument measurement method)”.
- plastics for forming the protective layer include plastics such as polyolefin, polyamide, and polyester.
- plastics such as polyolefin, polyamide, and polyester.
- polyolefin plastic are the same as those exemplified above.
- polyamide-based plastic include nylon 6, nylon 6, 6, nylon 6 and 10 nylons, and the like.
- polyester plastic include polyethylene terephthalate and polybutylene terephthalate.
- the plastic forming the plastic pharmaceutical liquid container is a multilayer film
- a specific embodiment thereof is, for example, as described above, the polyolefin plastic in the innermost layer forming the inner surface side of the plastic pharmaceutical liquid container. It has a strong sealing layer, and has a protective layer on the outermost layer on the outer side of the plastic drug solution container, and also has a polyol plastic force between the sealing layer and the protective layer.
- a multilayer film having a three-layer structure having an intermediate layer may be mentioned.
- the multilayer film preferably further has a low water-absorbing layer having a low water-absorbing plastic force on the inner side surface (sealing layer side) of the plastic pharmaceutical solution container relative to the intermediate layer.
- a low water-absorbing layer having a low water-absorbing plastic force on the inner side surface (sealing layer side) of the plastic pharmaceutical solution container relative to the intermediate layer.
- low water-absorbing plastic examples include polycyclic olefin.
- Polycyclic olefin is extremely low in water absorption rate. Specifically, it is 0.01% or less. Therefore, it is suitable for achieving the object of reducing the influence of moisture on the intermediate layer, which also has a polyol plastic power.
- polyolefins include, for example, a copolymer of ethylene and a dicyclopentagen compound (or a hydrogenated product thereof), and a copolymer of ethylene and a norbornene compound (or a compound thereof). Hydrogenated products), ring-opening polymers of cyclopentagen compounds (or hydrogenated products thereof), ring-opening copolymers composed of two or more cyclopentagen compounds (or hydrogenated products thereof), etc.
- polycyclic olefins include, for example, a copolymer of ethylene and a dicyclopentagen compound (or a hydrogenated product thereof), and a copolymer of ethylene and a norbornene compound (or a compound thereof). Hydrogenated products), ring-opening polymers of cyclopentagen compounds (or hydrogenated products thereof), ring-opening copolymers composed of two or more cyclopentagen compounds (or hydrogenated products thereof), etc.
- polycyclic olefins include, for example, a cop
- the multilayer film may be provided with a layer made of a plastic containing an elastomer for the purpose of imparting flexibility, transparency and impact resistance to a plastic drug container, for example. Monkey.
- elastomer examples include polyolefin elastomers such as polyethylene elastomers and polypropylene elastomers, and examples include styrene ethylene Z butylene styrene block copolymer (SEBS), styrene butadiene styrene block copolymer (SBS).
- SEBS styrene ethylene Z butylene styrene block copolymer
- SBS styrene butadiene styrene block copolymer
- Styrene isoprene styrene block copolymer (SIS), modified SEBS modified with maleic acid, styrene-ethylene Z-propylene-styrene block copolymer (SEPS), styrene-ethylene Z-butylene block copolymer (SEB), Examples thereof include styrene-based elastomers such as styrene-ethylene Z-propylene block copolymer (SEP), and among them, polyethylene-based elastomers are preferable.
- SIS Styrene isoprene styrene block copolymer
- SEPS styrene-ethylene Z-propylene-styrene block copolymer
- SEB styrene-ethylene Z-butylene block copolymer
- SEP styrene-ethylene Z-propylene block copolymer
- polyethylene-based elastomers are preferable.
- the plastic forming the plastic pharmaceutical solution container is not limited to this, and examples thereof include those formed into a film by an extrusion method such as a T-die method or an inflation method.
- a plastic drug solution container having excellent flexibility and flexibility can be formed.
- FIGS. 1 to 3 are schematic cross-sectional views showing preferred embodiments of the layer structure of the multilayer film when the plastic forming the plastic pharmaceutical solution container is a multilayer film. That is, as a preferable embodiment in the case of exerting power, it is not limited to this, but for example, (I) Sealing layer 1 consisting of a mixed resin of polyethylene and polypropylene, layer 2 consisting of polyethylene, in order from the innermost layer forming the inner side I of the plastic drug container to the outermost layer forming the outer side o And a low water-absorbing layer 3 that also becomes a polycyclic polyolefin, an intermediate layer 4 that also has an ethylene-vinyl alcohol copolymer power, and a protective layer 5 that has a polyethylene power. Further, the low water-absorbing layer 3 and the intermediate layer 4 And between the intermediate layer 4 and the protective layer 5, respectively, have adhesive layers 6, 7 made of adhesive resin (for example, adhesive polyolefin, etc.), Multilayer film (see Figure 1),
- the sealing layer 1 made of a mixed resin of polyethylene and polypropylene, and the layer 2 made of polyethylene in that order.
- An intermediate layer 4 made of an ethylene butyl alcohol copolymer, and a protective layer 5 made of polyethylene, and between the layer 2 and the intermediate layer 4 made of polyethylene, and the intermediate layer 4 and the protective layer
- a 6-layer multilayer film (see Fig. 2) having adhesive layers 8 and 7 each made of an adhesive resin (for example, adhesive polyolefin, etc.)
- an adhesive is applied between the low water absorption layer 3 and the intermediate layer 4 or between the intermediate layer 4 and the protective layer 5 in each layer. This can be achieved. Further, an adhesive layer made of an adhesive resin may be interposed in the same manner as in the case of the multilayer film shown in the above (I) and ( ⁇ ). On the other hand, in the multilayer film shown in the above (I) and (i), the adhesion between the low water absorption layer 3 and the intermediate layer 4 and the adhesion between the intermediate layer 4 and the protective layer 5 are performed between each layer. , 7, 8), simply by applying an adhesive.
- the thickness of each layer is not particularly limited, and as a whole plastic pharmaceutical liquid container, oxygen permeability after steam sterilization or hot water sterilization, and steady state If the oxygen permeability is set to meet the above range,
- the thickness of the intermediate layer should be 3 to 20 ⁇ m, and the total thickness of the multilayer film should be about 180 to 300 ⁇ m. Is preferred.
- the form of the plastic pharmaceutical liquid container is not particularly limited, and as described above, for example, a bag-shaped chemical liquid container excellent in flexibility and flexibility, such as an infusion bag (see FIG. 4).
- a bag-shaped chemical liquid container excellent in flexibility and flexibility such as an infusion bag (see FIG. 4).
- it may be a chemical container such as an infusion bottle that has flexibility and flexibility while maintaining the container shape by itself.
- the bag-shaped chemical solution container such as the infusion nose may be a single-solution chemical solution bag or a so-called multi-chamber bag having a plurality of storage chambers partitioned by easy-peeling seal portions. Good.
- the method for forming these infusion bags, infusion bottles and the like is not particularly limited, and various methods such as laminating and coextrusion, for example, may be appropriately selected and employed depending on the form of the chemical solution container. Can do.
- the chemical solution accommodated in the plastic drug container in the present invention is not particularly limited, and various drugs can be mentioned.
- the above-mentioned plastic pharmaceutical solution containers have reduced oxygen intrusion from the outside in the normal environment where the chemical solution containers are used, and the strength of oxygen absorption after steam sterilization treatment or hot water sterilization treatment is also reduced. It is housed in an outer bag with oxygen barrier properties together with the agent and sealed, so that oxygen remaining in the head space and dissolved oxygen in the chemical solution can be removed over time.
- an infusion solution in particular, an infusion solution containing an easily oxidizable substance such as L-cystine, L-tryptophan, fat, vitamin A, vitamin B, and vitamin C is preferable.
- the outer bag has an oxygen barrier property, and has an oxygen permeability at a temperature of 25 ° C and a humidity of 60% RH, preferably 0.5 cm 3 Zm 2 '24h' atm or less, more preferably 0.1 cm 3 Z24h'm 2 'atm or less.
- the outer bag has a certain water vapor permeability. In this case, the moisture in the outer bag can be released to the outside, and the oxygen permeability of the plastic pharmaceutical solution container tends to be in a steady state.
- the water vapor permeability of the outer bag is preferably about 0.5 to 30 gZm 2 ′ 24 h, although there is a balance with oxygen barrier properties.
- the forming material of the outer bag is not particularly limited, for example,
- the inner side of the outer bag a heat-sealable plastic (for example, polyolefin such as polyethylene and polypropylene), and a laminated layer on the outer side of the outer bag than the molten adhesive layer
- a heat-sealable plastic for example, polyolefin such as polyethylene and polypropylene
- a laminated layer on the outer side of the outer bag than the molten adhesive layer A multilayer film having an aluminum foil
- Examples of the inorganic oxide in the vapor-deposited film of the inorganic oxide include, for example, alumina (aluminum oxide), silica (cyanide oxide), magnesium oxide, titanate. Examples include fleas. Among these, from the viewpoint of the transparency of the deposited film, preferably, alumina is used. Further, as a material for forming the outer bag having a certain water vapor permeability, for example, polyvinyl alcohol or A multilayer film in which a plastic layer having an appropriate oxygen barrier property and water vapor permeability is laminated, such as polyvinyl chloride and polyvinylidene.
- the outer bag forming material exemplified above may further be subjected to light-shielding printing using an ink containing a colorant or an ultraviolet absorber on the outer surface side of the outer bag.
- a strong protective film such as polyester or polyolefin may be laminated on the outer side of the outer bag.
- the oxygen scavenger is not particularly limited, and various oxygen scavengers can be mentioned. Specific examples include those containing iron compounds such as iron hydroxide, iron oxide and iron carbide as active ingredients, and those using low-molecular phenol and activated carbon. It is.
- Commercially available oxygen scavengers include, for example, the registered trademark “AGELESS” manufactured by Mitsubishi Gas Chemical Co., Ltd., the product name “Modulan” manufactured by Nippon Gyaku Co., Ltd., and products manufactured by Nippon Soda Co., Ltd. The name “SEKIYURU” and the registered trademark “TAMOTSU” manufactured by Oji Chemical Co., Ltd.
- the oxygen scavenger is, for example, a chemical container that has been subjected to steam sterilization treatment or hot water sterilization treatment in a state in which the bag has a high oxygen permeability and is filled with a plastic film (eg, polyolefin). At the same time, it can be accommodated in the outer bag.
- a plastic film eg, polyolefin
- the chemical container container and the manufacturing method thereof of the present invention for example, even a chemical liquid containing an easily oxidizable substance can be stored stably for a long period of time without causing acid deterioration.
- the chemical solution bag when used, it is possible to prevent the acid solution from deteriorating.
- the components of the plastic pharmaceutical solution container forming plastic are as follows.
- PE (1) Ethylene ⁇ 1-butene copolymer (density 0.940g / cm 3 , water vapor permeability 7g / m 2 '24h (25 ° C, 90% RH, 20 111), trade name "Ultzex ( (Registered trademark) 40208 ", Prime Polymer Co., Ltd.)
- PE (2) Ethylene 1-butene copolymer (density 0.920 gZcm 3 , trade name “Ultzex (registered trademark) 2010”, Prime Polymer Co., Ltd.) 45% by weight, ethylene 1-butene copolymer Polymer (density 0.885 g / cm 3 , trade name “Tuffmer (registered trademark) A0585X”, made by Prime Polymer Co., Ltd.) 50% by weight, polyethylene homopolymer (density 0.965 g / cm 3 , trade name “Hi-X) (R) 65150BJ, Ltd. Prime polymer) a mixture of 5 wt% • EVOH (l): ethylene content 27 mol 0/0, trade name "Ebaru (registered trademark) L101", Ltd. Kuraray )
- EVOH (2) ethylene content of 44 mole 0/0, the trade name of "Ebaru (registered trademark) E105", Co., Ltd. Kuraray) • COP: Norbornene-based ring-opening polymer hydrogenated product (water absorption of less than 0.01%, trade name “ZENOA (registered trademark) 1020RJ, manufactured by ZEON CORPORATION)”
- Each layer shown in Table 1 was co-extruded so as to be laminated in the order shown in Table 1 to obtain a multilayer film for forming a chemical solution bag (plastic pharmaceutical solution container) 10 shown in FIG.
- This multilayer film is a seven-layer film shown in FIG.
- the water vapor permeability of the laminate comprising the protective layer 5 and the adhesive layer 7 of the multilayer film was 4. lg / m 2 -24 h (25. C, 90% RH).
- the two multilayer films described above were overlapped and the peripheral edge portion 11 was heat-sealed according to a conventional method, thereby producing a chemical solution bag 10 shown in FIG.
- the port member 12 was a port-type mouth member formed using the PE (1).
- Each layer shown in Table 1 was co-extruded so as to be laminated in the order shown in Table 1 to obtain a multilayer film for forming the drug solution bag 10.
- This multilayer film is a six-layer film shown in FIG.
- a chemical solution bag 10 shown in Fig. 4 was produced in the same manner as in Example 1 except that the two multilayer films described above were used.
- a chemical solution bag 10 shown in Fig. 4 was produced in the same manner as in Example 1 except that the two multilayer films described above were used.
- Each layer shown in Table 1 was co-extruded so as to be laminated in the order shown in Table 1 to obtain a multilayer film for forming the drug solution bag 10.
- This multilayer film is a V, 5-layer film without an adhesive layer.
- a chemical solution bag 10 shown in Fig. 4 was produced in the same manner as in Example 1 except that the two multilayer films described above were used.
- Table 1 shows the layer configuration of the chemical solution bag 10 and the oxygen permeability of the multilayer film forming the chemical solution bag 10 for Examples 1-2 and Comparative Examples 1-2.
- Adhesive layer (20ju m) (20ju m) (20ju m)
- the unit of oxygen permeability is cm "7 m 2 '24h' atm.
- the multilayer film obtained in Example 1 was subjected to high-pressure steam sterilization for 30 minutes in a steam-saturated nitrogen atmosphere (temperature 110.C, pressure 2700 hPa), and then the surface of the multilayer film was heated to about 40 ° C. Water was removed with warm air for 1 minute. After steam sterilization, this multilayer film is left for 3 weeks in an atmosphere at a temperature of 25 ° C and humidity of 60% RH to change the oxygen permeability (temperature 25 ° C, humidity 60% RH) over time. Observed. For measurement of oxygen permeability, a trade name “OX-TRAN (registered trademark)” manufactured by MOCON was used.
- FIG. 5 is a graph showing measurement results of changes in oxygen permeability over time. As shown in Figure 5 In addition, it took about 3 days after the steam sterilization process until the oxygen permeability (temperature 25 ° C, humidity 60% RH) of the multilayer film reached a steady state.
- the drug solution bags 10 produced in Examples 1-2 and Comparative Examples 1-2 were each filled with 300 mL of distilled water for injection and sealed.
- the headspace volume was about 30 mL, and nitrogen substitution (about 50%) was performed so that the oxygen concentration became 10%.
- each chemical solution bag 10 in a sterilization kettle and heating in a steam-saturated nitrogen atmosphere (temperature 110 ° C, pressure 2700 hPa) for 30 minutes, high-pressure steam sterilization is performed. Treated. The oxygen concentration in the nitrogen atmosphere was adjusted to 2% or less.
- the outer surface of the medicinal solution bag 10 was removed by blowing hot air of about 40 ° C for 1 minute to remove water. After removing the water from the force, it was housed in an outer bag together with an oxygen scavenger (Mitsubishi Gas Chemical Co., Ltd .; trade name “AGELESS (registered trademark))” and sealed to obtain a chemical container container.
- an oxygen scavenger Mitsubishi Gas Chemical Co., Ltd .; trade name “AGELESS (registered trademark)
- the outer bag is a bag body having a three-layer multilayer film force in which the inner side layer is polyethylene, the intermediate layer is polybulal alcohol, the outer side is stretched polypropylene, and the temperature is 25 ° C, humidity
- the oxygen permeability at 60% RH was 0.1 lcm 3 Zm 2 '24h' atm or less, and the water vapor permeability at a temperature of 25 ° C and a humidity of 90% RH was 0.5 gZm 2 '24h.
- this outer bag was adjusted so that the volume of the inner space was about 300 to 500 mL, and the oxygen concentration in the outer bag became 2% or less by nitrogen replacement.
- the chemical container containers obtained in Examples 1 and 2 and Comparative Examples 1 and 2 are each left in an environment of a temperature of 25 ° C. and a humidity of 60% RH, and the oxygen contained in the contents liquid every day The concentration was measured with a non-destructive oxygen concentration meter (product name “Fibox 3”, manufactured by PreSens).
- the chemical container container used in the above evaluation test 1 is further allowed to stand for 7 days from the production of the chemical container container to bring the oxygen concentration in the contents liquid close to Oppm, then at a temperature of 25 ° C and humidity Remove the chemical bag 10 from the outer bag in an environment of 60% RH and leave it in an environment with a temperature of 25 ° C and a humidity of 60% RH for a specified time. Each time, the oxygen concentration in the liquid contents was measured with a nondestructive oxygen concentration meter (“Fibox 3” above).
- the chemical container container obtained in Example 1 above (specimen different from those used in Evaluation Tests 1 and 2) was left for various days in an environment of temperature 25 ° C and humidity 60% RH, respectively. After each product was taken out, the chemical solution bag was taken out, the film was cut off and the moisture was wiped off, and then the oxygen permeability was measured using the product name “OX-TRAN (registered trademark)” manufactured by MOCON. did. The results are shown in Fig. 8.
- the oxygen permeability (temperature 25 ° C, humidity 60% RH) of the multilayer film is about 3-4 days after high-pressure steam sterilization treatment because it was wrapped in an outer bag. Showed a high value. It was also found that it takes about 10 days after steam sterilization for oxygen permeability to reach a steady state. Therefore, after the steam sterilization treatment and before the oxygen permeability returns to a steady state, the oxygen in the chemical solution bag 10 can be sufficiently absorbed by the oxygen scavenger.
- the layers shown in Table 2 are coextruded so as to be laminated in the order shown in Table 2 to form a chemical solution bag (plastic pharmaceutical solution container) 10 shown in FIG.
- a multilayer film was obtained.
- This multilayer film is a seven-layer film shown in Fig. 1. Is.
- the water vapor permeability of the laminate composed of the protective layer 5 and the adhesive layer 7 of the multilayer film was 4. lg / m 2 -24h (25 ° C, 90% RH).
- the two multilayer films described above were overlapped and the peripheral edge portion 11 was heat-sealed in accordance with a conventional method, thereby producing a chemical solution bag 10 shown in FIG.
- the port member 12 was a port-type mouth member formed using the PE (1).
- Each layer shown in Table 2 was co-extruded so as to be laminated in the order shown in Table 2 to obtain a multilayer film for forming the drug solution bag 10.
- This multilayer film is a seven-layer film shown in FIG.
- the water vapor permeability of the laminate comprising the protective layer 5 and the adhesive layer 7 of the multilayer film was 7. Og / m 2 -24h (25 ° C, 90% RH).
- a chemical solution bag 10 shown in FIG. 4 was produced in the same manner as in Example 3 except that the above-described two multilayer films were used.
- Each layer shown in Table 2 was co-extruded so as to be laminated in the order shown in Table 2 to obtain a multilayer film for forming the drug solution bag 10.
- This multilayer film is a six-layer film shown in FIG.
- the water vapor permeability of the laminate comprising the protective layer 5 and the adhesive layer 7 of the multilayer film was 5. lg / m 2 -24h (25 ° C, 90% RH).
- a chemical solution bag 10 shown in Fig. 4 was produced in the same manner as in Example 3 except that the above-described two multilayer films were used.
- Each layer shown in Table 2 was co-extruded so as to be laminated in the order shown in Table 2 to obtain a multilayer film for forming the drug solution bag 10.
- This multilayer film is a seven-layer film shown in FIG.
- the water vapor permeability of the laminate comprising the protective layer 5 and the adhesive layer 7 of the multilayer film was 3.2 g / m 2 -24 h (25 ° C., 90% RH).
- a chemical solution bag 10 shown in Fig. 4 was produced in the same manner as in Example 3 except that the above-described two multilayer films were used.
- Table 2 shows the layer configuration of the chemical solution bag 10 and the oxygen permeability of the multilayer film forming the chemical solution bag 10 for Examples 3 to 6. [0075] [Table 2]
- the unit of oxygen permeability is cm m 2 '24h'atm.
- the unit of water vapor permeability is g / m 24h.
- the drug solution bags 10 prepared in Examples 3 to 6 were each filled with 300 mL of distilled water for injection and sealed.
- the headspace volume was about 30 mL, and nitrogen substitution (about 50%) was performed so that the oxygen concentration became 10%.
- each chemical solution bag 10 was placed in a sterilization kettle and heated in a steam-saturated nitrogen atmosphere (temperature 110 ° C., pressure 2700 hPa) for 30 minutes to perform high-pressure steam sterilization.
- the oxygen concentration in the nitrogen atmosphere was adjusted to 2% or less.
- the outer surface force of the chemical solution bag 10 is also removed by spraying warm air of about 40 ° C for 1 minute to remove water, and then the oxygen scavenger (manufactured by Mitsubishi Gas Chemical). And a product name “AGELESS (registered trademark)”), and the product was accommodated in an outer bag and sealed to obtain a chemical container container.
- the outer bag is a bag made of a multilayer film having a three-layer structure in which the inner side layer is polyethylene, the intermediate layer is polybutyl alcohol, and the outer side is also stretched polypropylene.
- Oxygen permeability force at temperature of 25 ° C and humidity 60% RH 0.lc m 3 Zm 2 '24h' atm or less
- water vapor permeability force at temperature of 25 ° C and humidity 90% RH 0.5g / Use m 2 ⁇ 24h.
- the intermediate layer is a bag body having a three-layered multilayer film structure in which the inner layer and the outer layer have a polyethylene force and the polyethylene layer has a temperature of 25 ° C and a humidity of 60.
- the outer bag was adjusted so that the volume of the internal space was about 300 to 500 mL, and the oxygen concentration in the outer bag became 2% or less by nitrogen substitution.
- Example 5 when a test similar to the above-described evaluation test 2 was performed, in Examples 3, 4 and 6, the oxygen contained in the content liquid was removed after 96 hours (4 days) from the outer bag. Since the concentration was below 0.5 ppm, it was found that oxygen penetration into the contents was suppressed as much as possible. On the other hand, in Example 5, after 72 hours (3 days) after taking out the outer bag force, the oxygen concentration in the content liquid was less than 2 ppm, and the intrusion of oxygen into the content liquid was sufficiently acceptable. I was acknowledged that it was.
- the present invention includes, for example, a chemical container, an infusion solution, It is suitable for use in medical containers such as containers, especially for use in medical containers that contain chemical solutions containing easily oxidizable substances.
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
- Wrappers (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06745438.9A EP1875889B1 (en) | 2005-04-28 | 2006-04-19 | Housing body for medical liquid container and process for producing the same |
CN2006800173080A CN101180026B (zh) | 2005-04-28 | 2006-04-19 | 药液容器收容体及其制造方法 |
US11/911,644 US8465819B2 (en) | 2005-04-28 | 2006-04-19 | Drug solution container package and method for manufacturing the same |
CA2604611A CA2604611C (en) | 2005-04-28 | 2006-04-19 | Drug solution container package and method for manufacturing the same |
DK06745438.9T DK1875889T3 (en) | 2005-04-28 | 2006-04-19 | Medical liquid container storage body and method of manufacture thereof |
JP2007514626A JP4939405B2 (ja) | 2005-04-28 | 2006-04-19 | 薬液容器収容体およびその製造方法 |
KR1020077026574A KR101231965B1 (ko) | 2005-04-28 | 2006-04-19 | 약액 용기 수용체 및 그 제조 방법 |
ES06745438.9T ES2529741T3 (es) | 2005-04-28 | 2006-04-19 | Cuerpo de alojamiento para envase de líquido médico y procedimiento para producir el mismo |
AU2006241992A AU2006241992B8 (en) | 2005-04-28 | 2006-04-19 | Drug solution container package and method for manufacturing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-132624 | 2005-04-28 | ||
JP2005132624 | 2005-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006118034A1 true WO2006118034A1 (ja) | 2006-11-09 |
Family
ID=37307835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/308206 WO2006118034A1 (ja) | 2005-04-28 | 2006-04-19 | 薬液容器収容体およびその製造方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8465819B2 (ja) |
EP (1) | EP1875889B1 (ja) |
JP (2) | JP4939405B2 (ja) |
KR (1) | KR101231965B1 (ja) |
CN (1) | CN101180026B (ja) |
AU (1) | AU2006241992B8 (ja) |
CA (1) | CA2604611C (ja) |
DK (1) | DK1875889T3 (ja) |
ES (1) | ES2529741T3 (ja) |
PT (1) | PT1875889E (ja) |
TW (1) | TWI299988B (ja) |
WO (1) | WO2006118034A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009014032A1 (ja) | 2007-07-20 | 2009-01-29 | Otsuka Pharmaceutical Factory, Inc. | 薬剤容器および多層フィルム |
JPWO2007055312A1 (ja) * | 2005-11-10 | 2009-04-30 | 田辺三菱製薬株式会社 | ピラゾロン化合物含有水溶液が充填されたプラスチック容器 |
JP2009153729A (ja) * | 2007-12-27 | 2009-07-16 | Dainippon Printing Co Ltd | 医療用プラスチック製容器用の包装袋 |
JP2009153730A (ja) * | 2007-12-27 | 2009-07-16 | Dainippon Printing Co Ltd | プレフィルドシリンジ用の包装袋 |
WO2015092328A1 (fr) * | 2013-12-20 | 2015-06-25 | bioMérieux | Utilisation de film polymere pour l'emballage de milieu de culture |
JP2016520553A (ja) * | 2013-04-08 | 2016-07-14 | イノファーマ ライセンシング エルエルシー | 酸化感受性製剤のための安定なすぐ使用できる注入バッグを製造するプロセス |
US9901513B2 (en) | 2006-10-27 | 2018-02-27 | Otsuka Pharmaceutical Factory, Inc. | Drug solution having reduced dissolved oxygen content, method of producing the same and drug solution containing unit having reduced dissolved oxygen content |
JP2019014137A (ja) * | 2017-07-06 | 2019-01-31 | 大日本印刷株式会社 | バリア性積層体および輸液バッグ用外装袋 |
JP7452219B2 (ja) | 2020-04-20 | 2024-03-19 | Ube株式会社 | ポリアミド樹脂組成物 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2266521T3 (da) * | 2008-03-14 | 2013-10-28 | Otsuka Pharma Co Ltd | Plastikampul |
CN102836066B (zh) * | 2008-03-14 | 2014-11-05 | 株式会社大塚制药工厂 | 着色塑料容器 |
US20100293892A1 (en) * | 2008-12-12 | 2010-11-25 | Edwards Lifesciences Corporation | Method of Packaging and Package for Sensors |
EP2398506B1 (en) * | 2009-02-13 | 2018-01-10 | Mercer Technologies Limited | Sterilisation services apparatus and method of sterilisation |
US20100247936A1 (en) * | 2009-03-24 | 2010-09-30 | Baxter International Inc. | Non-pvc films with tough core layer |
JP5491514B2 (ja) * | 2009-10-02 | 2014-05-14 | 株式会社細川洋行 | 収容容器 |
CN102883960B (zh) | 2010-02-16 | 2015-08-19 | 耐斯特科技有限公司 | 具有复合灵活壁的流体容器 |
FR2995789A1 (fr) * | 2012-09-25 | 2014-03-28 | Pharmadyne | Utilisation d'une poche preremplie en perfusion ambulatoire |
BR112015022171B1 (pt) | 2013-03-14 | 2023-01-03 | Fresenius Kabi Deutschland Gmbh | Sistema de embalagem farmacêutica para um fármaco sensível ao oxigênio injetável |
CA2902343C (en) | 2013-03-14 | 2022-08-02 | Becton Dickinson France S.A.S. | Injectable morphine formulations |
FR3015439B1 (fr) * | 2013-12-20 | 2017-03-24 | Biomerieux Sa | Utilisation de film polymere pour l'emballage de milieu de culture |
CN107106409A (zh) * | 2014-10-02 | 2017-08-29 | 泰尔茂株式会社 | 用于容纳蛋白质溶液制剂的医疗用容器 |
CN107073889B (zh) * | 2014-10-03 | 2019-06-28 | 三井化学东赛璐株式会社 | 层叠膜、输液袋用外包装袋及输液袋包装体 |
CN108910262A (zh) * | 2017-04-01 | 2018-11-30 | 南京光谷数据处理有限公司 | 用于氧化干燥型油墨的环保回收包装物 |
PL3804686T3 (pl) * | 2017-10-10 | 2023-12-11 | Sun Pharmaceutical Industries Ltd | Dożylna infuzyjna postać dawkowania dla pemetreksedu |
FR3097736B1 (fr) * | 2019-06-26 | 2021-07-09 | Ceva Sante Animale | Conditionnements polymeriques et leur utilisation pour conserver une composition pharmaceutique |
KR102246313B1 (ko) * | 2020-06-17 | 2021-04-29 | 에스알테크노팩 주식회사 | 수액 용기용 다층 필름 및 그 제조 방법, 이를 포함하는 수액 용기 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63275346A (ja) | 1987-05-07 | 1988-11-14 | Terumo Corp | 輸液剤の包装体 |
JPH04276253A (ja) * | 1991-03-04 | 1992-10-01 | Nippon Zeon Co Ltd | 医療用または食品包装用容器 |
JPH1080464A (ja) | 1996-09-06 | 1998-03-31 | Material Eng Tech Lab Inc | ガスバリアー性を有する輸液容器 |
JPH11285520A (ja) | 1998-04-01 | 1999-10-19 | Mitsui Chem Inc | 薬品容器用フィルム |
JP2003010287A (ja) * | 2001-03-27 | 2003-01-14 | Nipro Corp | アルブミン溶液収容プラスチック容器 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55131049A (en) * | 1979-04-02 | 1980-10-11 | Sumitomo Chem Co Ltd | Novel thermoplastic resin composition |
GB2025895B (en) * | 1979-07-17 | 1982-10-13 | Montedison Spa | Bags made of composite thermoplastic films for preserving transfusion blood |
JPS57206447A (en) * | 1981-06-12 | 1982-12-17 | Terumo Corp | Plastic container receiving liquid drug pasturized with high pressure steam and production thereof |
WO1988008694A1 (en) | 1987-05-07 | 1988-11-17 | Terumo Kabushiki Kaisha | Packed transfusion |
JPH0624575B2 (ja) | 1989-01-30 | 1994-04-06 | 森下ルセル株式会社 | 輸液入り合成樹脂容器の製造方法 |
JP2716514B2 (ja) * | 1989-03-31 | 1998-02-18 | 住友ベークライト株式会社 | 積層体 |
US5032632A (en) * | 1990-05-15 | 1991-07-16 | E. I. Du Pont De Nemours And Company | Oxidation-resistant ethylene vinyl alcohol polymer compositions |
JP2960520B2 (ja) * | 1990-10-09 | 1999-10-06 | 株式会社細川洋行 | バリアー性輸液包装材 |
JP3030525B2 (ja) * | 1991-07-29 | 2000-04-10 | キョーラク株式会社 | 薬液用プラスチック容器 |
JPH0767936A (ja) | 1993-07-12 | 1995-03-14 | Otsuka Pharmaceut Factory Inc | 輸液容器 |
US5766751A (en) * | 1994-01-24 | 1998-06-16 | Sumitomo Chemical Company, Ltd. | Laminate, laminate film and shaped article comprising inorganic laminar compound |
CA2165209A1 (en) * | 1994-04-20 | 1995-11-02 | Yoshitomi Pharmaceutical Industries Ltd. | Container filled with infusion liquids, infusion preparation and high calorie infusion preparation comprising vitamins |
JP2932162B2 (ja) | 1995-10-05 | 1999-08-09 | テルモ株式会社 | アミノ酸及び還元糖電解質を含有する輸液剤 |
ES2163574T3 (es) * | 1995-12-04 | 2002-02-01 | Jms Co Ltd | Recipiente para uso medico. |
SE9601348D0 (sv) * | 1996-04-10 | 1996-04-10 | Pharmacia Ab | Improved containers for parenteral fluids |
JP3700039B2 (ja) * | 1997-01-20 | 2005-09-28 | 株式会社大塚製薬工場 | プラスチックフィルム製複室容器 |
JP3906455B2 (ja) | 1998-05-11 | 2007-04-18 | 株式会社大塚製薬工場 | 多層フィルム及びその製品 |
US6713137B1 (en) * | 1998-11-23 | 2004-03-30 | Fresenius Kabi Ab | Medical containers |
JP4492985B2 (ja) * | 2000-02-24 | 2010-06-30 | 三菱商事プラスチック株式会社 | 液体医薬品用プラスチック容器及び液体医薬品の保存回収方法 |
JP2002160771A (ja) * | 2000-11-24 | 2002-06-04 | Material Eng Tech Lab Inc | 複室容器 |
JP2002173171A (ja) * | 2000-12-05 | 2002-06-18 | Mitsubishi Engineering Plastics Corp | 積層フィルム製の医療溶液用袋 |
DE60234142D1 (de) | 2001-03-27 | 2009-12-10 | Nipro Corp | Albuminlösung enthaltender Kunststoffbehälter |
US6698213B2 (en) * | 2001-05-22 | 2004-03-02 | Integrated Biosystems, Inc. | Systems and methods for freezing and storing biopharmaceutical material |
FI20011686A0 (fi) | 2001-08-22 | 2001-08-22 | Wihuri Oy | Hörysterilisoitava monikerroskalvo sekä siitä valmistettavat säilytysastiat |
DE60211731T2 (de) | 2001-11-01 | 2007-05-16 | Integrated Biosystems Inc., Napa | Vorrichtung und verfahren zum einfrieren und zur lagerung von biopharmazeutischem material |
JP2003205014A (ja) | 2002-01-10 | 2003-07-22 | Fumio Murai | 加熱処理済複室容器 |
CA2482520C (en) * | 2002-04-30 | 2011-01-04 | Otsuka Pharmaceutical Factory, Inc. | Multiple-chamber medical container and bag for enclosing same |
JP2004128248A (ja) * | 2002-10-03 | 2004-04-22 | Nikon Corp | 磁気遮蔽部材、磁気シールドルーム及び露光装置 |
PT1616549E (pt) * | 2003-04-23 | 2012-11-12 | Otsuka Pharma Co Ltd | Ampola de plástico de enchimento de uma solução de fármaco e processo para a sua produção |
WO2005004902A1 (ja) | 2003-07-10 | 2005-01-20 | Nipro Corporation | プラスチック容器入り組換えヒト血清アルブミン製剤 |
JP4535840B2 (ja) | 2003-10-28 | 2010-09-01 | 株式会社大塚製薬工場 | 医療用複室容器の製造方法 |
JP2005304911A (ja) * | 2004-04-23 | 2005-11-04 | Inter Medic Kk | 医療用複室容器及びその製造方法 |
JP2006020657A (ja) | 2004-07-05 | 2006-01-26 | Otsuka Pharmaceut Factory Inc | 微量元素配合輸液製剤 |
JP4488907B2 (ja) | 2005-01-05 | 2010-06-23 | 株式会社大塚製薬工場 | 医療用二重包装製剤の製造方法および医療用二重包装製剤 |
JP4607609B2 (ja) | 2005-02-08 | 2011-01-05 | 株式会社大塚製薬工場 | 薬液バッグ、薬液バッグ収容体および薬液バッグ収容体の製造方法 |
-
2006
- 2006-04-19 PT PT67454389T patent/PT1875889E/pt unknown
- 2006-04-19 CA CA2604611A patent/CA2604611C/en not_active Expired - Fee Related
- 2006-04-19 US US11/911,644 patent/US8465819B2/en active Active
- 2006-04-19 EP EP06745438.9A patent/EP1875889B1/en active Active
- 2006-04-19 WO PCT/JP2006/308206 patent/WO2006118034A1/ja active Application Filing
- 2006-04-19 ES ES06745438.9T patent/ES2529741T3/es active Active
- 2006-04-19 AU AU2006241992A patent/AU2006241992B8/en not_active Ceased
- 2006-04-19 DK DK06745438.9T patent/DK1875889T3/en active
- 2006-04-19 KR KR1020077026574A patent/KR101231965B1/ko active IP Right Grant
- 2006-04-19 JP JP2007514626A patent/JP4939405B2/ja active Active
- 2006-04-19 CN CN2006800173080A patent/CN101180026B/zh active Active
- 2006-04-28 TW TW095115250A patent/TWI299988B/zh active
-
2011
- 2011-08-05 JP JP2011172243A patent/JP5167392B2/ja active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63275346A (ja) | 1987-05-07 | 1988-11-14 | Terumo Corp | 輸液剤の包装体 |
JPH04276253A (ja) * | 1991-03-04 | 1992-10-01 | Nippon Zeon Co Ltd | 医療用または食品包装用容器 |
JPH1080464A (ja) | 1996-09-06 | 1998-03-31 | Material Eng Tech Lab Inc | ガスバリアー性を有する輸液容器 |
JPH11285520A (ja) | 1998-04-01 | 1999-10-19 | Mitsui Chem Inc | 薬品容器用フィルム |
JP2003010287A (ja) * | 2001-03-27 | 2003-01-14 | Nipro Corp | アルブミン溶液収容プラスチック容器 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1875889A4 |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013189469A (ja) * | 2005-11-10 | 2013-09-26 | Mitsubishi Tanabe Pharma Corp | ピラゾロン化合物含有水溶液が充填されたプラスチック容器 |
JPWO2007055312A1 (ja) * | 2005-11-10 | 2009-04-30 | 田辺三菱製薬株式会社 | ピラゾロン化合物含有水溶液が充填されたプラスチック容器 |
JP5973118B2 (ja) * | 2005-11-10 | 2016-08-23 | 田辺三菱製薬株式会社 | ピラゾロン化合物含有水溶液が充填されたプラスチック容器 |
US9901513B2 (en) | 2006-10-27 | 2018-02-27 | Otsuka Pharmaceutical Factory, Inc. | Drug solution having reduced dissolved oxygen content, method of producing the same and drug solution containing unit having reduced dissolved oxygen content |
JP5330240B2 (ja) * | 2007-07-20 | 2013-10-30 | 株式会社大塚製薬工場 | 薬剤容器および多層フィルム |
EP2174636A4 (en) * | 2007-07-20 | 2011-08-31 | Otsuka Pharma Co Ltd | MEDICAMENT CONTAINER AND MULTILAYER FILM |
US8328783B2 (en) | 2007-07-20 | 2012-12-11 | Otsuka Pharmaceutical Factory, Inc. | Drug container and multilayer film |
CN101754742B (zh) * | 2007-07-20 | 2013-05-01 | 株式会社大塚制药工厂 | 药剂容器及多层薄膜 |
EP2174636A1 (en) * | 2007-07-20 | 2010-04-14 | Otsuka Pharmaceutical Factory, Inc. | Medicine container and multilayer film |
WO2009014032A1 (ja) | 2007-07-20 | 2009-01-29 | Otsuka Pharmaceutical Factory, Inc. | 薬剤容器および多層フィルム |
JP2009153730A (ja) * | 2007-12-27 | 2009-07-16 | Dainippon Printing Co Ltd | プレフィルドシリンジ用の包装袋 |
JP2009153729A (ja) * | 2007-12-27 | 2009-07-16 | Dainippon Printing Co Ltd | 医療用プラスチック製容器用の包装袋 |
JP2019081767A (ja) * | 2013-04-08 | 2019-05-30 | イノファーマ ライセンシング エルエルシー | 酸化感受性製剤のための安定なすぐ使用できる注入バッグを製造するプロセス |
JP2016520553A (ja) * | 2013-04-08 | 2016-07-14 | イノファーマ ライセンシング エルエルシー | 酸化感受性製剤のための安定なすぐ使用できる注入バッグを製造するプロセス |
WO2015092328A1 (fr) * | 2013-12-20 | 2015-06-25 | bioMérieux | Utilisation de film polymere pour l'emballage de milieu de culture |
JP2017502886A (ja) * | 2013-12-20 | 2017-01-26 | ビオメリューBiomerieux | 培養培地の包装用ポリマーフィルムの使用 |
US20160354998A1 (en) * | 2013-12-20 | 2016-12-08 | Biomerieux | Use of polymer film for packaging a culture medium |
EP3450330A1 (fr) * | 2013-12-20 | 2019-03-06 | bioMérieux | Utilisation de film polymère pour l'emballage de milieu de culture |
FR3015438A1 (fr) * | 2013-12-20 | 2015-06-26 | Biomerieux Sa | Utilisation de film polymere pour l'emballage de milieu de culture |
US10538067B2 (en) | 2013-12-20 | 2020-01-21 | Biomerieux | Use of polymer film for packaging a culture medium |
JP2019014137A (ja) * | 2017-07-06 | 2019-01-31 | 大日本印刷株式会社 | バリア性積層体および輸液バッグ用外装袋 |
JP7452219B2 (ja) | 2020-04-20 | 2024-03-19 | Ube株式会社 | ポリアミド樹脂組成物 |
Also Published As
Publication number | Publication date |
---|---|
JP2011212505A (ja) | 2011-10-27 |
EP1875889B1 (en) | 2014-11-26 |
JP5167392B2 (ja) | 2013-03-21 |
KR101231965B1 (ko) | 2013-02-08 |
CA2604611C (en) | 2013-10-22 |
CN101180026B (zh) | 2012-02-22 |
PT1875889E (pt) | 2015-01-14 |
EP1875889A4 (en) | 2013-11-27 |
TW200716079A (en) | 2007-05-01 |
EP1875889A1 (en) | 2008-01-09 |
TWI299988B (en) | 2008-08-21 |
JP4939405B2 (ja) | 2012-05-23 |
CA2604611A1 (en) | 2006-11-09 |
US20090032426A1 (en) | 2009-02-05 |
DK1875889T3 (en) | 2014-12-08 |
JPWO2006118034A1 (ja) | 2008-12-18 |
AU2006241992B8 (en) | 2011-11-17 |
AU2006241992A1 (en) | 2006-11-09 |
ES2529741T3 (es) | 2015-02-25 |
KR20080003423A (ko) | 2008-01-07 |
AU2006241992B2 (en) | 2011-11-03 |
US8465819B2 (en) | 2013-06-18 |
CN101180026A (zh) | 2008-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5167392B2 (ja) | 薬液容器収容体およびその製造方法 | |
US5129894A (en) | Package units for medical purposes | |
EP0686091B1 (en) | Autoclavable multilayer films | |
EP2303570B1 (en) | Evoh barrier film with reduced autoclave shock | |
TWI437984B (zh) | 醫療容器用多層體及醫療容器 | |
WO2009081462A1 (ja) | 医療容器用多層体および医療容器 | |
JP5587597B2 (ja) | 包装体 | |
JP2005349182A (ja) | 薬剤容器 | |
JP3700039B2 (ja) | プラスチックフィルム製複室容器 | |
JP3906455B2 (ja) | 多層フィルム及びその製品 | |
KR100740508B1 (ko) | 이중 챔버 수액 용기 및 이에 적용되는 다층 필름 | |
JPH0525503B2 (ja) | ||
US8025977B2 (en) | Multilayer film | |
JP5106804B2 (ja) | 多層容器の製造方法 | |
JP4506241B2 (ja) | 密封容器の製造方法 | |
RU2448677C2 (ru) | Многослойный корпус для медицинских контейнеров и медицинский контейнер | |
JP2020157571A (ja) | 積層体、包装体及び包装物品 | |
JP4273260B2 (ja) | 容器入り食品または医薬品の製造方法 | |
JPS6239470A (ja) | 酸素により変質することのない薬液入りプラスチツク容器の製造方法 | |
JPH10277134A (ja) | 酸素易変質性薬剤入り容器の包装体及びその滅菌処理方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680017308.0 Country of ref document: CN |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2604611 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11911644 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006241992 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007514626 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006745438 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2006241992 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077026574 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006745438 Country of ref document: EP |